Navigation Links
Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time
Date:7/28/2011

ation 68.8 64.9 132.3 129.1 Share based compensation 19.2 12.6 34.9 26.7 Gain on sale of non-current investments - - - (11.1) Loss/(gain) on sale of product rights 2.2 (4.1) 3.5 (4.1) Other 1.1 5.7 (5.7) 11.0 Movement in deferred taxes (24.5) 6.5 17.7 58.8 Equity in earnings of equity method investees (1.2) (1.0) (2.4) (0.5) Changes in operating assets and liabilities: Decrease/(increase) in accounts receivable 18.6 (33.1) (56.2) (43.9) Increase in sales deduction accrual 34.9 89.3 66.1 154.3 Increase in inventory (17.9) (25.8) (30.6) (50.1) Increase in prepayments and other assets (18.8) (64.5) (13.8) (83.3) (Decrease)/increase in accounts payable and other liabilities (4.3) 72.8 (77.1) (43.2) Net cash provided by operating activities(A) 283.6 283.8 485.5 469.9

Unaudited US GAAP results for the three months and six months to June 30, 2011
Consolidated Statements of Cash Flows (continued)

3 months to 3 months to 6 months to 6 months to June 30, June 30, June 30, June 30, 2011 2010 2011 2010 $M $M $M $M CASH FLOWS FROM INVESTING ACTIVITIES: Movements in restricted cash 8.9 (0.3) 4.8 6.0 Purchases of subsidiary undertakings, net of cash acquired (719.7) - (719.7) - Purchases of non-current investments (2.0) - (4.5) - Purchases of property, plant and equipment ("PP&E") (48.5) (164.6) (95.0) (208.1) Purchases of intangible assets - (2.7) - (2.7) Proceeds from disposal of non-current investments, PP&E and product rights 6.8 - 6.9 2.1 Returns of equity investments and proceeds from short term investments 0.5 - 1.6 - Net cash used in investing activities(B) (754.0) (167.6) (805.9) (202.7) CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from drawing of revolving credit facility 30.0 - 30.0 - Repayment of debt acquired with ABH (13.1) - (13.1) - Payment under building finance obligation (0.2) (0.7) (0.4) (1.3) Extinguishment of building finance obligation - (43.1) - (43.1) Tax benefit of stock ba
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. Neogen Reports 27% Increase in Quarterly Net Income
2. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
3. Microbix Has Best-Ever Quarterly Sales
4. Amylin Pharmaceuticals Announces Third Quarter Product Revenues; Quarterly Update Conference Call Canceled
5. China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
6. Shires Replenished Portfolio Drives Excellent Quarterly Performance
7. Quest Diagnostics Declares Quarterly Cash Dividend
8. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
9. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
10. Abbott Declares 343rd Consecutive Quarterly Dividend
11. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Wheaton, Illinois (PRWEB) May 04, 2015 ... treatment options for patients with arm and hand ... rehabilitation exoskeleton at its Oakbrook Terrace network site. ... foundation, the Armeo®Spring is a highly-regarded treatment option ... In acquiring the Armeo®Spring, Marianjoy becomes one of ...
(Date:5/1/2015)... 2015 OncoTAb, Inc., a ... company, announced that Pinku Mukherjee, Ph.D. has received the ... of Governors’ highest faculty honor. Mukherjee received the award, ... for her innovative research and development of cancer diagnostics ... a crowning moment in my scientific career,” said Mukherjee, ...
(Date:5/1/2015)... 2015 Pfenex Inc. (NYSE MKT: PFNX), ... of biosimilar therapeutics including high value and difficult ... quarter 2015 financial results will be released on ... market. At 8:30 am Eastern Time, Pfenex management will ... results and provide a business update. A press release ...
(Date:5/1/2015)... , May 1, 2015 A ... for antithrombotic drugs will reach $22.4bn in 2019. That ... World Industry and Market Prospects 2015-2025 , ... that investigation is to provide forecasts and qualitative analyses ... information publisher and consultancy in London, UK ...
Breaking Biology Technology:Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2OncoTAb CSO Awarded the University of North Carolina’s O. Max Gardner Award 2Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 4Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 5
... , London, July 20 There ... in the pharmaceutical and biotechnology space. While the economic downturn and ... for the recent M&A mania, which has including four mega M&As ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , , ...
... , EDMONTON, July 17 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: ... (MS), today announced financial and operational results for the three ... phase III MAESTRO-01 trial has completed the last patient last ... the second half of this year. This is the first ...
... 17 Encorium Group, Inc. (Nasdaq: ... organization (CRO) that provides design, development, and management capabilities ... the world,s leading pharmaceutical companies, today announced that is ... U.S. business to Pierrel Research USA, Inc., a wholly-owned ...
Cached Biology Technology:Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities 2BioMS Medical announces second quarter 2009 results 2BioMS Medical announces second quarter 2009 results 3BioMS Medical announces second quarter 2009 results 4BioMS Medical announces second quarter 2009 results 5BioMS Medical announces second quarter 2009 results 6BioMS Medical announces second quarter 2009 results 7BioMS Medical announces second quarter 2009 results 8BioMS Medical announces second quarter 2009 results 9Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 2Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 3Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 4
(Date:4/8/2015)... 8, 2015  Infinisource, a leading provider of SaaS-based ... Morpho, a leading supplier of biometric identification and ... market,s most advanced biometrically-enabled time clock, the companies ... clock is setting a bold, new standard for ... the small and mid-size employer. When connected to ...
(Date:4/2/2015)... , April 2, 2015 At its ... Salt Lake City , the American College of ... five new directors to its Board.  Members of the ... ACMG and for forming and advancing its policies and ... genetics profession. "It,s an eventful time in ...
(Date:4/1/2015)... , Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... Wocket smart wallets is underway to early access pre-order ... group includes usage at retail outlets including Walmart, Target, ... Users report Wocket was accepted at all outlets and ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... Technologies was chosen for multiple reasons: to initiate a ... provide society with security of energy supply and to ... a European graduate school is thought to be the ... to foster the development of excellent young scientists, presenting ...
... of years, humans have evolved to naturally understand things like ... researcher has found there is an ever-widening gap between what ... to be successful adults in today,s modern society. Schools have ... but in the U.S. more may need to be done. ...
... Netherlands, June 09, 2009 / b3c newswire / ... the Netherlands Organisation for Applied Scientific Research TNO today ... to further develop Amarna’s viral gene delivery platform ... methods for the manufacture, formulation and testing of viral ...
Cached Biology News:MU study finds connection between evolution, classroom learning 2Amarna Therapeutics B.V. and TNO announce SVac research and development partnership 2Amarna Therapeutics B.V. and TNO announce SVac research and development partnership 3
Affinity Purified Rabbit Anti-mouse sRANKL Biotinylated Polyclonal Antibody...
Rabbit polyclonal to FOXJ2 ( Abpromise for all tested applications). entrezGeneID: 55810 SwissProtID: Q9P0K8...
Selenoprotein P Purified Anti-Mouse clone 35, Isotype Mouse IgG 2b , 50 µg Consult technical datasheet for details....
Mouse monoclonal [3B6] to HSV1 + HSV2 ICP5 Major Capsid Protein ( Abpromise for all tested applications)....
Biology Products: